Episode Details

This episode explores iX Biopharma’s strategic pivot toward high-growth wellness and the U.S. compounding pharmacy market. We delve into their proprietary sublingual technology, which offers superior absorption and immediate commercial potential. Learn how a disciplined focus on longevity and clinical-ready assets is transforming their financial landscape.

• Uncover the explosive momentum within the longevity segment and the flagship supplement captivating global consumers

• Discover a capital-light pathway for rapid entry into the American healthcare market

• Get updates on a breakthrough pain-management platform attracting major government interest